Drugs of Abuse (DOA) Testing Market Analysis, Share And Growth 2025 To 2034


Crafted for informed planning, this report explores the forces reshaping the drugs of abuse (doa) testing market and what they mean for business leaders.

What Is The Projected Market Size & Growth Rate Of The Drugs of Abuse (DOA) Testing Market?
The drugs of abuse (doa) testing market size has grown strongly in recent years. It will grow from $7.3 billion in 2024 to $7.97 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to government regulations and workplace policies, pre-employment screening, law enforcement and legal procedures, drug rehabilitation programs, transportation industry compliance.

The drugs of abuse (doa) testing market size is expected to see strong growth in the next few years. It will grow to $11.21 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to expanding sports and athletics testing, increasing awareness and education, rise in drug-related crimes, corporate wellness programs, advancements in testing methods. Major trends in the forecast period include use of portable and handheld testing devices, implementation of laboratory information management systems (LIMS), emphasis on synthetic drug testing, increasing demand for cannabis testing, integration of artificial intelligence (AI) for result interpretation.

Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9381&type=smp

What Is The Crucial Factor Driving The Global Drugs of Abuse (DOA) Testing Market?
Increasing demand for drug abuse treatment is expected to propel the growth of the drugs of abuse (DOA) testing market going forward. Drug abuse or substance abuse refers to the use of a substance in quantities that are harmful to the user or others. Drug testing aids in the identification of compounds that are not normally found in the body. The process starts with a screening test, which is followed by a second test to find and/or confirm the presence of a substance or substances, so increasing demand for drug abuse treatment will propel the market's growth. For instance, in December 2023, the Government of the United Kingdom (GOV. UK), a UK-based government platform, reported that between April 2022 and March 2023, 290,635 adults accessed drug and alcohol services, a slight increase from 289,215 in the previous year. Treatment admissions also rose to 137,749, compared to 130,490 and 133,704 in the prior two years. Therefore, increasing demand for drug abuse treatment is driving the drug of abuse (DOA) testing market.

Segment Covered In The Drugs of Abuse (DOA) Testing Market Report
The drugs of abuse (doa) testingmarket covered in this report is segmented –

1) By Product And Service: Analyzers; Rapid Testing Devices; Consumables; Laboratory Services
2) By Sample Type: Urine; Hair; Oral Fluid; Breath
3) By Application: Pain Management; Criminal Justice; Workplace Screening
4) By End User: Hospitals; Diagnostic Laboratories; Forensic Laboratories; Other End Users

Subsegments:
1) By Analyzers: Immunoassay Analyzers; Chromatography-Based Analyzers; Mass Spectrometry Systems
2) By Rapid Testing Devices: Urine Test Kits; Saliva Test Kits; Hair Test Kits
3) By Consumables: Test Strips; Reagents; Sample Collection Devices
4) By Laboratory Services: Toxicology Testing; Confirmation Testing; Screening Services

Key Trends Driving Growth In The Drugs of Abuse (DOA) Testing Market
Major companies operating in the drugs of abuse (DOA) testing market are focused on developing innovative products such as software-as-a-service platform to strengthen their position in the market. Software-as-a-Service (SaaS) is a software distribution model in which applications are hosted by a third-party provider and made available to customers over the internet. For instance, in December 2023, Merck KGaA, a US-based science and technology company launched Addison drug discovery software. The program expedites drug development and raises the success rate of novel medications and therapies by fusing computer-aided drug design, machine learning, and generative AI. The platform then makes suggestions for the best ways to synthesis these medications, bridging the gap between the design of virtual molecules and their practical manufacturability. The program increases the likelihood that patients will benefit from novel treatments by drawing out hidden insights from large datasets.

Key Player In The Drugs of Abuse (DOA) Testing Market
Major companies operating in the drugs of abuse (DOA) testing market include Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., bioMérieux Inc., Dragerwerk AG & Co. KGaA, Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories

View the full drugs of abuse (doa) testing market report here:
https://www.thebusinessresearchcompany.com/report/drugs-of-abuse-doa-testing-global-market-report

Global Drugs of Abuse (DOA) Testing Market - Regional Insights:
North America was the largest region in the drugs of abuse (DOA) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global drugs of abuse (DOA) testing market report during the forecast period. The regions covered in the drugs of abuse (doa) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more